Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

GERCOR - Multidisciplinary Oncology Cooperative Group: Clinical Trials & FDA Approval Profile

GERCOR - Multidisciplinary Oncology Cooperative Group (Global / Institutional) sponsors 16 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 14 active protocols (4 recruiting now), 1 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)6.3%
Median Closed Enrollment vs National (145 pts)73 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for GERCOR - Multidisciplinary Oncology Cooperative Group
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)16
Active Pipeline (Recruiting Now)14 (4)
Completed vs Stopped Early1 / 1 (6.3%)
Median Closed Actual Enrollment73 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With GERCOR - Multidisciplinary Oncology Cooperative Group
Hospital Research SiteLocationShared Protocols
Hôpital Saint-AntoineParis12
CHU PoitiersPoitiers, New Aquitaine11
Centre Léon BérardLyon7

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by GERCOR - Multidisciplinary Oncology Cooperative Group
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06253611First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric CancerPhase IIRECRUITING
NCT06059495DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II StudyPhase IIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the GERCOR - Multidisciplinary Oncology Cooperative Group Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI